Current and future therapies for gout-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current and future therapies for gout

Published:2017-07-28 Issue:12 Volume:18 Page:1201-1211
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Pascart Tristan¹²,Richette Pascal³⁴

Affiliation:

1. Department of Rheumatology, Lille Catholic Hospitals, University of Lille, Lomme, France

2. EA 4490, PMOI, Physiopathologie des Maladies Osseuses Inflammatoires, University of Lille, Lille, France

3. Department of Rheumatology, Assistance Publique-Hôpitaux de Paris, Hôpital Lariboisiere, Paris, France

4. INSERM U1132 and University Paris-Diderot, Paris, France

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2017.1351945

Reference95 articles.

2. Improving cardiovascular and renal outcomes in gout: what should we target?

3. High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study

4. GOSPEL 2 – Colchicine for the treatment of gout flares in France – a GOSPEL survey subgroup analysis. Doses used in common practices regardless of renal impairment and age

5. Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gout risk in adults with pre-diabetes initiating metformin;Annals of the Rheumatic Diseases;2024-05-15

2. Gout Management Using Nanocarrier Systems: A Review;ACS Applied Nano Materials;2024-04-22

3. Preparation, characterisation, and pharmacodynamic study of myricetin pH-sensitive liposomes;Journal of Microencapsulation;2024-04-15

4. Proline-derived quinoline formamide compounds as human urate transporter 1 inhibitors with potent uric acid-lowering activities;European Journal of Medicinal Chemistry;2024-04

5. Trends in healthcare utilization by patients with gout: A cross-sectional study using Health Insurance Review and Assessment Service data;Medicine;2024-02-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3